Alex Brindle holds a B.Sc. in chemistry, a M.Sc. in analytical science and a Ph.D. in process engineering; additionally. He has over 10 years experience within development and manufacturing. His experience includes petrochemicals, consumer healthcare and life sciences (in both development and manufacturing) and he has worked at Shell, AstraZeneca and GlaxoSmithKline before joining NNE Pharmaplan. At NNE Pharmaplan Alex holds a senior consulting role. He takes responsibility for Front-End Studies for capital investment projects (Feasibility, Global Site Selection and Conceptual Design) in addition to leading various strategic projects related to 21st century (QbD and PAT) pharmaceuticals. Alex’s broad experience within life science makes him knowledgeable within all phases of development and operations for both pharmaceuticals (API and Secondary) and Biotech (API and fill/finish).